Breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) is a rare type
of lymphoma that is most commonly associated with textured breast implants.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Anaplastic T-cell lymphoma in proximity to a saline filled breast implant.Plast Reconstr Surg. 1997; 100: 554-555
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms.Blood. 2016; 127: 2375-2390
- NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). T-Cell Lymphomas, Version 1.2021-October 5, 2020.(Available at:) (Accessed November 23, 2020)
- Breast implant-associated anaplastic large cell lymphoma – A systematic review.JAMA Surg. 2017; 152: 1161-1168
- Current risk estimate of breast implant-associated anaplastic large cell lymphoma in textured breast implants.Plast Reconstr Surg. 2019; 143: 30S-40S
- U.S. epidemiology of breast implant-associated anaplastic large cell lymphoma.Plast Reconstr Surg. 2017; 139: 1042-1050
- Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): an overview of presentation and pathogenesis and guidelines for pathological diagnosis and management.Histopathology. 2019; 75: 787-796
- Genetics of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).Aesthet Surg J. 2019; 39: S14-S20
- Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A.Br J Hematol. 2018; 180: 735-760
- How to diagnose and treat breast implant-associated anaplastic large cell lymphoma.Plast Reconstr Surg. 2018; 141: 586e-599e
- American Society of Plastic Surgeons BIA-ALCL PROFILE (Patient Registry and Outcomes for breast Implants and anaplastic large cell Lymphoma etiology and Epidemiology) registry.(Available at:) (Accessed November 25, 2020)
- 2019 NCCN Consensus Guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).Aesthet Surg J. 2019; 39: S3-S13
- Characteristics and treatment of advanced breast implant-associated anaplastic large cell lymphoma.Plast Reconstr Surg. 2019; 143: 41S-50S
- The FDA requests allergan voluntarily recall natrelle BIOCELL textured breast implants and tissue expanders from the market to protect patients: FDA safety communications.(Available at:) (Accessed November 12, 2020)
- Breast implants – certain labeling recommendations to improve patient communication.(Available at:) (Accessed November 12, 2020)
Article info
Publication history
Published online: July 05, 2021
Identification
Copyright
© 2021 Elsevier Inc. All rights reserved.
